Korea Zinc's Major Shareholders Seek Ban on New Share Sale
By Kwanwoo Jun
Major shareholders at Korea Zinc, the world's largest zinc smelter pushing for a multi-billion-dollar U.S. joint venture, have sought a court injunction to stop its plans to issue shares to fund the project.
Private equity firm MBK Partners and Young Poong, which claim to hold a combined stake of well over 40% in Korea Zinc, said they filed a complaint with the Seoul Central District Court on Tuesday to block the company's planned rights issue.
Korea Zinc's stock fell 14% to close at 1,370,000 won, equivalent to $932.75, in Seoul Tuesday, highlighting renewed market jitters over the ongoing dispute between Chairman Yun B. Choi and the rival MBK-Young Poong alliance for control over the company.
The stock erased its nearly 5% gain in the prior session on news of the joint venture. The benchmark Kospi closed 2.2% lower on Tuesday.
MBK and Young Poong said their move was not aimed at opposing Korea Zinc's plan to build a $7.43 billion smelter in the U.S. but to block the planned share issuance which they say was structured to preserve Chairman Choi's control over the company.
Write to Kwanwoo Jun at kwanwoo.jun@wsj.com
(END) Dow Jones Newswires
December 16, 2025 02:48 ET (07:48 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
5 Stocks to Buy Trading at Big Discounts
2 Undervalued Stocks to Buy With Long-Term Growth Ahead
What 7 Key Market Indicators Are Telling Investors Right Now
The Market May Be Too Pessimistic About This 4-Star Dividend Stock
United States